This is a routine scheduling announcement with no material content. The key event to watch is the May 13 conference call, where management may provide Q1 financials and an update on the funding situation flagged in the 20-F. No immediate trading action warranted.
Price Chart
Executive Summary
Innate Pharma filed a 6-K announcing a Q1 2026 business update conference call scheduled for May 13, 2026. The filing contains no financial results, clinical data, or material operational developments — it is a routine scheduling notice. The prior 20-F flagged a critical funding gap and going concern risk, but this filing provides no new information on that front.
Key Facts
- Conference call scheduled for May 13, 2026 at 1:30 PM CEST / 7:30 AM EDT
- Call will feature CEO, CMO, COO, CFO, and VP of IR
- No financial results, clinical data, or material business updates disclosed
- Prior 20-F (April 1, 2026) highlighted cash runway into Q3 2026 and need for non-dilutive financing
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No new information on the going concern risk or funding gap identified in the prior 20-F
- Potential negative surprise if the May 13 call reveals worsening cash position or lack of financing progress
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-030874 |
| Document: a260506_6k.htm | 0001628280-26-030874 |
| Document: 0001628280-26-030874-index-headers.html | 0001628280-26-030874 |
| Document: 0001628280-26-030874-index.html | 0001628280-26-030874 |
| Document: 0001628280-26-030874.txt | 0001628280-26-030874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 19, 2026 22w ago | 6-K | $2.25 $1.65 | ▼ −26.67% | ▼ −32.96% | $1.51 (−32.93%) |
May 13, 2026 23w ago | 6-K | $1.50 $1.65 | ▼ −10.00% | ▼ −5.56% | $1.51 (−0.60%) |
May 6, 2026 24w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +7.94% | $1.51 (+0.60%) |
Apr 23, 2026 26w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +4.98% | $1.51 (+0.60%) |
Apr 17, 2026 27w ago | 6-K | $1.50 $1.65 | ▲ +10.00% | ▲ +3.86% | $1.51 (+0.60%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 13, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +11.25% | $1.51 (+9.91%) |
Apr 8, 2026 28w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +9.72% | $1.51 (+9.91%) |
Apr 3, 2026 29w ago | 6-K | $1.37 $1.65 | ▲ +20.17% | ▲ +6.71% | $1.51 (+9.91%) |
Apr 1, 2026 29w ago | 20-F | $1.37 $1.65 | ▼ −20.17% | ▼ −6.80% | $1.51 (−9.91%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers